Hysterectomy Clinical Trial
— PeTraHOfficial title:
Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial
Verified date | October 2015 |
Source | Hillerod Hospital, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: National Board of Health |
Study type | Interventional |
In Denmark, 4400 women annually undergo hysterectomy on benign background (surgical removal of the uterus). 10% of these women experience bleeding complications. The drug Tranexamic Acid (Cyklokapron) has showed significant reduction of bleeding in relation to other types of surgery. The hypothesis of this study is that Tranexamic Acid could also reduce the operative bleeding associated with benign hysterectomy. The study will be carried out as a randomized, placebo-controlled national multicenter trial
Status | Completed |
Enrollment | 332 |
Est. completion date | October 2015 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: • Women over 18 who is to undergo elective benign hysterectomy Exclusion Criteria: - Known thrombophilia - Active / previous thromboembolic disease - Family history of thromboembolic disease (thrombophilia in the family) - Hypersensitivity to any ingredient in Tranexamic acid - Renal impairment - Ongoing hematuria - Subarachnoid hemorrhage - Daily use of any type of blood thinners (Clopidogrel / Marevan / Warfarin / Nonsteroidal Antiinflammatory Drugs (not when pain is the indication)) - Preoperative use of Tranexamic acid within 24 hours of the operation - Known malignancy or hysterectomy as part of the investigation for suspected malignancy - Insufficient understanding of the information concerning the project: language disabilities, intellectual limitations, or the like. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Denmark | Department of gynecology and obstetrics, Nordsjællands Hospital | Hillerød |
Lead Sponsor | Collaborator |
---|---|
Hillerod Hospital, Denmark | Central Denmark Region, Odense University Hospital, Research grant from Nordsjællands Hospital, Rigshospitalet, Denmark, The Danish hysterectomy and hysteroscopy database, The fund of Olga Bryde |
Denmark,
Astedt B, Liedholm P, Wingerup L. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynaecol. 1978;67(6):203-5. — View Citation
Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ. 1996 Sep 7;313(7057):579-82. — View Citation
Coulter A, Kelland J, Peto V, Rees MC. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care. 1995 Summer;11(3):456-71. — View Citation
CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. — View Citation
Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32. Review. — View Citation
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001886. doi: 10.1002/14651858.CD001886.pub4. Review. — View Citation
Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(4):CD000249. Review. — View Citation
Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010 Oct;116(4):865-75. doi: 10.1097/AOG.0b013e3181f20177. — View Citation
Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011 Jan;93(1):39-46. doi: 10.1302/0301-620X.93B1.24984. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraoperative bleeding | In relation to the trial there is at set of standards to objectify blood loss during surgery. Output and input will be weighed and will form the basis of the calculated operative blood loss | 1 day (Bleeding is measured immediately after surgery) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05337566 -
Does Additional Use of Preoperative Azithromycin Decrease Posthysterectomy Infections
|
N/A | |
Recruiting |
NCT04130464 -
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
|
Phase 4 | |
Recruiting |
NCT05537727 -
Robotic MIS With Dexter
|
||
Completed |
NCT05037383 -
Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions
|
N/A | |
Completed |
NCT04080323 -
Single-dose Vaginal Dinoprostone and Hysterectomy
|
Phase 3 | |
Not yet recruiting |
NCT06011538 -
Web-based Versus Standard Information for Same Day Hysterectomy (WISH)
|
N/A | |
Completed |
NCT03187327 -
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
|
N/A | |
Terminated |
NCT00551785 -
Surveillance Study of Women Taking Intrinsa®
|
Phase 4 | |
Completed |
NCT00528177 -
Morphine vs. Oxycodone for Postoperative Pain Management
|
Phase 4 | |
Completed |
NCT03641625 -
Effect of SmtO2 Guided Care on PONV (iMODIPONV)
|
N/A | |
Terminated |
NCT03500744 -
Erector Spinae Plane Block for Major Gynecologic and Urologic Surgery
|
N/A | |
Recruiting |
NCT03294343 -
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
|
N/A | |
Completed |
NCT03610425 -
A Standardized Bundle Protocol to Optimize Outcomes With Patients Undergoing Gynecological Surgery
|
||
Completed |
NCT05659303 -
Evaluation of an Outpatient Protocol in Patients Operated for Laparoscopic Hysterectomy
|
||
Completed |
NCT05270447 -
Short-Term Effects of Connective Tissue Massage After Hysterectomy
|
N/A | |
Recruiting |
NCT05031182 -
Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.
|
N/A | |
Completed |
NCT03634306 -
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
|
N/A | |
Completed |
NCT01526668 -
Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
|
N/A | |
Recruiting |
NCT05374720 -
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
|
N/A | |
Recruiting |
NCT04109989 -
Clinical Assessment - HominisTM Surgical System
|
N/A |